Outbreak InvestigationNCT05123729
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
An observational study of Outbreak Investigation, run by Wake Forest University Health Sciences at 1 site in United States.
Trial summary
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Outbreak Investigation
- What is being tested?
- Crowdsourced campaign package, Rapid Response Teams and Registry enrollment
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 64 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Apr 2025to 18 Jun 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: NC residents residing in urban and rural communities
All individuals aged 18+ years are eligible for study participation. Each phase may have additional requirements, including residency in North Carolina, employment at a local health department, etc. Participants must be able to complete study activities independently and have the capacity to consent to study participation.
Trial locations and contacts
1 site in 1 country.
United States1 site
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157
About this study
Official title: Community-Academic Partnerships to Address Disparities Within Rural and Urban Communities
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
Read the detailed description
NPIs that are community-driven and developed in collaboration with diverse partners, including community members, public health agencies, and researchers may offer an acceptable and effective approach to reducing viral transmission and addressing individual and socio-structural barriers that lead to worse virus-related outcomes. Our study goals are to use a crowdsourcing open call to identify exceptional ideas (e.g., messages, videos, communication and dissemination strategies) that promote disease testing and encourage the public to practice the 3 Ws, referred to as health-promotive behaviors.
- Conditions
- Outbreak Investigation
- Being tested
- Crowdsourced campaign package, Rapid Response Teams, Registry enrollment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Crowdsourced campaign packageBehavioural
Disease prevention intervention developed using a crowdsourcing process.
Rapid Response TeamsBehavioural
Pilot a new hybrid training focused on contact tracing and case investigation.
Registry enrollmentOther
Participants join research registry
| Study group | Role | What they receive |
|---|---|---|
| Crowdsourced campaign package | Disease prevention intervention developed using a crowdsourcing process. Receives: Behavioral: Crowdsourced campaign package | |
| Rapid Response Team | Pilot a new hybrid training focused on contact tracing and case investigation. Receives: Behavioral: Rapid Response Teams | |
| Registry enrollment | Participants elect to enroll in research registry Receives: Other: Registry enrollment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants enrolled as measured by enrollment log
Number of participants enrolled as measured by enrollment log
Measured: Up to 5 years
Registry enrollment
Number of participants who join research registry
Measured: Up to 4 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Nov 2021
- Study start5 Apr 2025
- Primary completion18 Jun 2025
- Study completion18 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Outbreak InvestigationStudies of the same condition, open and under way.
- More trials run by Wake Forest University Health SciencesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 64 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wake Forest University Health Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Tiarney Ritchwood, PhD, Principal investigator, Wake Forest University Health Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05123729
- Sponsor's protocol ID
- IRB00099888
- Other IDs
- 40010565
- Status last verified
- Aug 2026
- First submitted
- 15 Nov 2021
- Last updated
- 29 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Community-Academic Partnerships to Address Disparities Within Rural and Urban Communities
- ClinicalTrials.gov ID
- NCT05123729
- Acronym / sponsor ID
- IRB00099888
- Conditions
- Outbreak Investigation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 64 participants (actual)
- Lead sponsor
- Wake Forest University Health SciencesUniversity, hospital or other
- Study start
- 5 Apr 2025 (actual)
- Primary completion
- 18 Jun 2025 (actual)
- Study completion
- 18 Jun 2025 (actual)
- First posted
- 17 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the impact of an intervention to increase viral transmission behaviors. The intervention will be developed through a crowdsourcing contest.
Detailed description
NPIs that are community-driven and developed in collaboration with diverse partners, including community members, public health agencies, and researchers may offer an acceptable and effective approach to reducing viral transmission and addressing individual and socio-structural barriers that lead to worse virus-related outcomes. Our study goals are to use a crowdsourcing open call to identify exceptional ideas (e.g., messages, videos, communication and dissemination strategies) that promote disease testing and encourage the public to practice the 3 Ws, referred to as health-promotive behaviors.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Crowdsourced campaign package | – | Behavioral: Crowdsourced campaign packageDisease prevention intervention developed using a crowdsourcing process. |
| Rapid Response Team | – | Behavioral: Rapid Response TeamsPilot a new hybrid training focused on contact tracing and case investigation. |
| Registry enrollment | – | Other: Registry enrollmentParticipants elect to enroll in research registry |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- NC residents residing in urban and rural communities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Crowdsourced campaign packageDisease prevention intervention developed using a crowdsourcing process. | Behavioural | Crowdsourced campaign package |
| Rapid Response TeamsPilot a new hybrid training focused on contact tracing and case investigation. | Behavioural | Rapid Response Team |
| Registry enrollmentParticipants join research registry | Other | Registry enrollment |
Primary outcome
Number of participants enrolled as measured by enrollment log
Time frame: Up to 5 years
Number of participants enrolled as measured by enrollment log
Registry enrollment
Time frame: Up to 4 years
Number of participants who join research registry
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Outbreak Investigation
Enrolling by invitationObservational study
Prospective Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria
Cystic Fibrosis, Nontuberculous Mycobacterial Pulmonary Infection
RecruitingPhase 4
BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies
Ebola, Bundibugyo Virus Disease (BVD)
RecruitingPhase 2/3
Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative)
Dengue
RecruitingObservational study
Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
Nontuberculous Mycobacterial Pulmonary Infection, Outbreak Investigation
RecruitingObservational study
Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions
Emerging Infectious Diseases, Communicable Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Tiarney Ritchwood, PhD principal investigator
Wake Forest University Health Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Outbreak Investigation, run by Wake Forest University Health Sciences at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants enrolled as measured by enrollment log (time frame: Up to 5 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.